The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire - PubMed (original) (raw)
Comparative Study
The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire
M T Scherer et al. J Exp Med. 1995.
Abstract
Most laboratory strains of mice have between two and eight endogenous superantigens. These viral superantigens (vSAGs) are coded by genes in the 3' long terminal repeats of endogenous mammary tumor viruses (Mtv's). A line of Mtv-negative mice and several lines of mice containing single Mtv's were created by inbreeding the F2 progeny of CBA/CaJ and C58/J mice, which have no Mtv integrants in common. This allowed the T cell repertoire of H-2k mice, unaffected by Mtv superantigens, as well as the effects of vSAGs upon that repertoire, to be studied. Although each individual mouse had a different mix of C58/J and CBA/CaJ background genes, the T cell repertoires of different Mtv-negative mice were very similar and were reproducible. Since the background genes did not affect the V beta repertoire, there are no super-antigens, other than those encoded by Mtv's, that differ between CBA/CaJ and C58/J. CD4 and CD8 T cells had quite different repertoires in the Mtv-negative mice because of the effects of class I and class II major histocompatibility complex molecules on positive and negative selection. vSAG3 was found to delete V beta 5 T cells, while vSAG8 deleted V beta 7 T cells, and vSAG9 deleted V beta 13 T cells in addition to their previously reported specificities. vSAG17 deletes a small proportion of CD4+ T cells bearing V beta 11 and -12. vSAG14 and -30 have little effect on the T cell repertoire and are not expressed in thymocytes and splenocytes. An endogenous superantigen that has a low avidity for a particular V beta may positively select thymocytes, leading to an increased frequency of peripheral T cells bearing the relevant V beta s. We found evidence that vSAG11 may positively select T cells bearing V beta 8.2. Our data, which analyzed the effects of seven endogenous Mtv's, showed little evidence of positive selection by any other vSAGs on T cells bearing any V beta tested, despite published reports to the contrary.
Similar articles
- Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E, Takacs K, Altmann DM. Simpson E, et al. Thymus. 1994;23(1):1-13. Thymus. 1994. PMID: 7863543 Review. - Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
Sheard MA, Sharrow SO, Takahama Y. Sheard MA, et al. Scand J Immunol. 2000 Dec;52(6):550-4. doi: 10.1046/j.1365-3083.2000.00814.x. Scand J Immunol. 2000. PMID: 11119259 - Identification of two V beta 7-specific viral superantigens.
Ignatowicz L, Kappler JW, Marrack P, Scherer MT. Ignatowicz L, et al. J Immunol. 1994 Jan 1;152(1):65-71. J Immunol. 1994. PMID: 8254207 - T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H. Braun MY, et al. Eur J Immunol. 1995 Mar;25(3):857-62. doi: 10.1002/eji.1830250334. Eur J Immunol. 1995. PMID: 7705418 - Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection.
Tomonari K, Fairchild S, Rosenwasser OA. Tomonari K, et al. Immunol Rev. 1993 Feb;131:131-68. doi: 10.1111/j.1600-065x.1993.tb01534.x. Immunol Rev. 1993. PMID: 8387455 Review.
Cited by
- Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.
Purdy A, Case L, Duvall M, Overstrom-Coleman M, Monnier N, Chervonsky A, Golovkina T. Purdy A, et al. J Exp Med. 2003 Jan 20;197(2):233-43. doi: 10.1084/jem.20021499. J Exp Med. 2003. PMID: 12538662 Free PMC article. - Prenatal Allogeneic Tolerance in Mice Remains Stable Despite Potent Viral Immune Activation.
Strong BS, Ryken KO, Lee AE, Turner LE, Wadhwani RK, Newkold TJ, Alhajjat AM, Heusel JW, Shaaban AF. Strong BS, et al. J Immunol. 2015 Oct 15;195(8):4001-9. doi: 10.4049/jimmunol.1500844. Epub 2015 Sep 11. J Immunol. 2015. PMID: 26363051 Free PMC article. - Intercellular transfer of a soluble viral superantigen.
Reilly M, Mix D, Reilly AA, Ye XY, Winslow GM. Reilly M, et al. J Virol. 2000 Sep;74(18):8262-7. doi: 10.1128/jvi.74.18.8262-8267.2000. J Virol. 2000. PMID: 10954523 Free PMC article. - HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, Belunis C, Bolin DR, Arceo R, Campbell R, Falcioni F, Vidović D, Hammer J, Nagy ZA. Ito K, et al. J Exp Med. 1996 Jun 1;183(6):2635-44. doi: 10.1084/jem.183.6.2635. J Exp Med. 1996. PMID: 8676084 Free PMC article. - Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
Barnett A, Mustafa F, Wrona TJ, Lozano M, Dudley JP. Barnett A, et al. J Virol. 1999 Aug;73(8):6634-45. doi: 10.1128/JVI.73.8.6634-6645.1999. J Virol. 1999. PMID: 10400761 Free PMC article.
References
- Nature. 1991 Mar 21;350(6315):203-7 - PubMed
- Nature. 1991 Feb 7;349(6309):526-8 - PubMed
- Eur J Immunol. 1991 Apr;21(4):1007-11 - PubMed
- Eur J Immunol. 1991 Dec;21(12):3035-40 - PubMed
- Immunogenetics. 1992;35(1):9-15 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous